Oxalyl-coenzyme A decarboxylase is a thiamin diphosphate-dependent enzyme that plays an important role in the catabolism of the highly toxic compound oxalate. We have determined the crystal structure of the enzyme from Oxalobacter formigenes from a hemihedrally twinned crystal to 1.73 Å resolution and characterized the steady-state kinetic behavior of the decarboxylase. The monomer of the tetrameric enzyme consists of three ␣/-type domains, commonly seen in this class of enzymes, and the thiamin diphosphatebinding site is located at the expected subunit-subunit interface between two of the domains with the cofactor bound in the conserved V-conformation. Although oxalyl-CoA decarboxylase is structurally homologous to acetohydroxyacid synthase, a molecule of ADP is bound in a region that is cognate to the FAD-binding site observed in acetohydroxyacid synthase and presumably fulfils a similar role in stabilizing the protein structure. This difference between the two enzymes may have physiological importance since oxalyl-CoA decarboxylation is an essential step in ATP generation in O. formigenes, and the decarboxylase activity is stimulated by exogenous ADP. Despite the significant degree of structural conservation between the two homologous enzymes and the similarity in catalytic mechanism to other thiamin diphosphate-dependent enzymes, the active site residues of oxalyl-CoA decarboxylase are unique. A suggestion for the reaction mechanism of the enzyme is presented.Oxalic acid is one of nature's most highly oxidized organic compounds, and its dianion is a strong chelator of metal cations, especially Ca 2ϩ , causing oxalate to be highly toxic to many organisms (1). In humans, elevated levels of oxalate are associated with several diseases, including the formation of calcium oxalate stones in the kidney (urolithiasis), renal failure, cardiomyopathy, and cardiac conductance disorders (1-3). Relatively large amounts of oxalate are introduced into the body through the diet, although this diacid may also arise as a byproduct of normal cellular metabolism (4). Because humans, in common with other mammals, are not able to degrade oxalate, this compound must be eliminated by excretion in the urine or via the intestine (5). The recent observation that a symbiotic, gut-dwelling bacterium, Oxalobacter formigenes, may regulate oxalate homeostasis in humans, therefore, has important implications for efforts to develop new strategies for treating oxalate-related diseases (6). O. formigenes is an obligate anaerobe bacterium found in the gastrointestinal tracts of vertebrates, including humans, and is unusual in that it employs oxalate as the sole energy source for its survival (7,8). As a result, this bacterium not only degrades free oxalate entering the intestine lumen but also creates a transepithelial gradient favoring oxalate secretion and preventing absorption of oxalic acid in the lower tract of the intestine (9). A direct correlation between the number of recurrent kidney stone episodes and a lack of O. formigenes in the ...